VectorB2B - Drug Development

VectorB2B-Drug Developing is a non-profit association created in 2019 that provides highly qualified services of drug discovery and development from the bench to bedside (B2B). Not only standard assays can be performed, but high added-value project design and innovative R&D solutions are available to customers. We act both as solution provider and solution enabler, meaning that the association provide original innovative assays not in the portfolio of conventional CROs or CMOs. This is possible because we incorporate knowledge and R&D from strong academic and biotech groups working in the forefront of the state of the art in biological drug/target discovery,...

Gmp production,biotech,pharmaceutical,toxicity,drug discovery,drug development,efficacy assays,process development,gmp production,biologics,clinical trials,project management,antibodies,scale up,and health

Vectorb2b - drug development operates in the Biotechnology industry.

Vectorb2b - drug development's revenue is 11m - 100m

Vectorb2b - drug development has 11 - 50 employees.